SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors-Reference-Cited by-同舟云学术

SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors

Published:2021-09-16 Issue:11 Volume:112 Page:4425-4432
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Nakamura Yoshiaki¹²,Fujisawa Takao²³,Taniguchi Hiroya¹²⁴,Bando Hideaki¹²^ORCID,Okamoto Wataru⁵,Tsuchihara Katsuya⁶^ORCID,Yoshino Takayuki¹^ORCID,Ohtsu Atsushi¹

Affiliation:

1. Department of Gastroenterology and Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan

2. Translational Research Support Section National Cancer Center Hospital East Kashiwa Japan

3. Department of Head and Neck Medical Oncology National Cancer Center Hospital East Kashiwa Japan

4. Department of Clinical Oncology Aichi Cancer Center Hospital Nagoya Japan

5. Cancer Treatment Center Hiroshima University Hospital Hiroshima Japan

6. Division of Translational Informatics Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15132

Reference36 articles.

1. National Comprehensive Cancer Network Guidelineshttps://wwwnccnorg/guidelines/category_1.2021. Accessed on July 21 2021.

2. The current state of molecular testing in the treatment of patients with solid tumors, 2019

3. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

4. The current status and problems confronted in delivering precision medicine in Japan and Europe

5. Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer registry as external control data for regulatory submission in Japan;ESMO Real World Data and Digital Oncology;2024-12

2. Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer;British Journal of Cancer;2024-08-28

3. Utility of Transpapillary Biopsy and Endoscopic Ultrasound-Guided Tissue Acquisition for Comprehensive Genome Profiling of Unresectable Biliary Tract Cancer;Cancers;2024-08-10

4. Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial;Journal of Clinical Oncology;2024-08-01

5. Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors;BJC Reports;2024-07-25